4//SEC Filing
Singleton Mark Leonard 4
Accession 0001578563-25-000191
CIK 0001665988other
Filed
Mar 24, 8:00 PM ET
Accepted
Mar 25, 5:37 PM ET
Size
5.4 KB
Accession
0001578563-25-000191
Insider Transaction Report
Form 4
Singleton Mark Leonard
SVP & CFO
Transactions
- Sale
Class A Common Stock
2025-03-24$9.79/sh−5,479$53,639→ 131,963 total
Footnotes (2)
- [F1]Reflects shares sold to cover taxes upon the vesting of restricted stock units on March 21, 2025 pursuant to a standing 10b5-1 instruction adopted on April 4, 2022.
- [F2]The price reported in Column 4 is a weighted average price calculated by the broker executing the sales transactions. These shares were sold as part of a trade comprised of shares of multiple employees of the Issuer in multiple transactions at prices ranging from $9.70 to $9.88, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the aggregate number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Bioventus Inc.
CIK 0001665988
Entity typeother
Related Parties
1- filerCIK 0001914936
Filing Metadata
- Form type
- 4
- Filed
- Mar 24, 8:00 PM ET
- Accepted
- Mar 25, 5:37 PM ET
- Size
- 5.4 KB